Q1 Earnings Estimate for Celanese Issued By Zacks Research

Celanese Corporation (NYSE:CEFree Report) – Equities researchers at Zacks Research cut their Q1 2026 earnings per share estimates for shares of Celanese in a research note issued to investors on Monday, March 9th. Zacks Research analyst Team now expects that the basic materials company will post earnings of $0.80 per share for the quarter, down from their previous estimate of $0.88. Zacks Research has a “Strong Sell” rating on the stock. The consensus estimate for Celanese’s current full-year earnings is $8.79 per share. Zacks Research also issued estimates for Celanese’s Q2 2026 earnings at $1.12 EPS, FY2026 earnings at $4.40 EPS, Q1 2027 earnings at $1.92 EPS, Q2 2027 earnings at $1.89 EPS, Q3 2027 earnings at $0.31 EPS, Q4 2027 earnings at $1.81 EPS and FY2027 earnings at $5.94 EPS.

A number of other equities analysts also recently issued reports on CE. Evercore set a $63.00 price objective on shares of Celanese in a report on Wednesday, February 18th. Robert W. Baird set a $65.00 price target on Celanese in a research note on Thursday, February 19th. Tudor Pickering upgraded Celanese from a “hold” rating to a “buy” rating in a research report on Monday. Weiss Ratings reiterated a “sell (d)” rating on shares of Celanese in a research report on Wednesday, January 21st. Finally, Morgan Stanley initiated coverage on Celanese in a report on Tuesday, January 20th. They set an “equal weight” rating and a $50.00 price target for the company. Nine research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $59.39.

Read Our Latest Report on CE

Celanese Trading Down 1.4%

NYSE CE opened at $50.74 on Wednesday. The company has a current ratio of 1.55, a quick ratio of 0.94 and a debt-to-equity ratio of 2.55. The business’s 50-day moving average price is $49.57 and its two-hundred day moving average price is $44.68. Celanese has a 12 month low of $35.13 and a 12 month high of $63.55. The firm has a market capitalization of $5.56 billion, a PE ratio of -4.79, a price-to-earnings-growth ratio of 0.37 and a beta of 1.07.

Celanese (NYSE:CEGet Free Report) last released its quarterly earnings data on Tuesday, February 17th. The basic materials company reported $0.67 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.22). The company had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.25 billion. Celanese had a negative net margin of 12.15% and a positive return on equity of 8.75%. Celanese’s revenue for the quarter was down 6.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.45 earnings per share. Celanese has set its Q1 2026 guidance at 0.700-0.850 EPS.

Celanese Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 24th were issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Tuesday, February 24th. Celanese’s dividend payout ratio (DPR) is currently -1.13%.

Hedge Funds Weigh In On Celanese

A number of institutional investors have recently bought and sold shares of CE. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in shares of Celanese by 41.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 32,450 shares of the basic materials company’s stock valued at $1,842,000 after purchasing an additional 9,543 shares during the period. NewEdge Advisors LLC raised its stake in Celanese by 265.2% during the first quarter. NewEdge Advisors LLC now owns 5,032 shares of the basic materials company’s stock worth $286,000 after purchasing an additional 3,654 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Celanese by 4.6% in the 2nd quarter. Envestnet Asset Management Inc. now owns 75,190 shares of the basic materials company’s stock valued at $4,160,000 after purchasing an additional 3,311 shares during the last quarter. Savant Capital LLC raised its position in Celanese by 106.9% in the second quarter. Savant Capital LLC now owns 8,928 shares of the basic materials company’s stock valued at $494,000 after purchasing an additional 4,613 shares during the period. Finally, Fox Run Management L.L.C. acquired a new position in shares of Celanese in the second quarter valued at approximately $460,000. 98.87% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Celanese

Here are the key news stories impacting Celanese this week:

  • Positive Sentiment: Tudor Pickering upgraded Celanese from “hold” to “buy,” signaling institutional conviction and providing upside momentum from an independent research shop. Celanese (NYSE:CE) Raised to “Buy” at Tudor Pickering
  • Positive Sentiment: Vertical Research also upgraded CE to “buy” with a $60 price target (roughly mid-to-high single-digit upside vs. current levels), which can support demand from investors who follow upgrades. Vertical Research Upgrades Celanese (NYSE:CE) to Buy
  • Neutral Sentiment: Zacks Research raised its Q3 2027 EPS forecast (from $0.16 to $0.31). This isolated upward revision is small and offset by broader negative revisions, so it is unlikely to materially change near-term consensus.
  • Negative Sentiment: Zacks Research issued a series of downward revisions across multiple quarters and years (Q1–Q4 2026 and Q1–Q4 2027 and FY2026–FY2027), trimming FY2026 to $4.40 and FY2027 to $5.94 from prior levels, and kept a “Strong Sell” rating — a broad negative signal that can pressure the stock and investor sentiment.
  • Negative Sentiment: Collectively, Zacks’ cuts reflect lower near-term earnings expectations versus prior forecasts and add to concerns after Celanese’s recent earnings miss and negative net margin; multiple downward revisions increase downside risk and may outweigh isolated buy-side upgrades. MarketBeat CE page

Celanese Company Profile

(Get Free Report)

Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.

In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.

Recommended Stories

Earnings History and Estimates for Celanese (NYSE:CE)

Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.